Free Trial

Ames National Corp Buys New Holdings in JPMorgan Chase & Co. (NYSE:JPM)

JPMorgan Chase & Co. logo with Finance background

Ames National Corp purchased a new position in shares of JPMorgan Chase & Co. (NYSE:JPM) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 9,260 shares of the financial services provider's stock, valued at approximately $2,220,000. JPMorgan Chase & Co. accounts for 1.4% of Ames National Corp's holdings, making the stock its 17th biggest position.

Several other institutional investors and hedge funds have also added to or reduced their stakes in JPM. Disciplined Investments LLC bought a new stake in JPMorgan Chase & Co. during the 4th quarter worth approximately $217,000. LGT Group Foundation boosted its position in shares of JPMorgan Chase & Co. by 2.8% during the fourth quarter. LGT Group Foundation now owns 525,801 shares of the financial services provider's stock valued at $126,040,000 after buying an additional 14,300 shares during the last quarter. Kinsale Capital Group Inc. grew its holdings in JPMorgan Chase & Co. by 11.1% during the fourth quarter. Kinsale Capital Group Inc. now owns 43,732 shares of the financial services provider's stock worth $10,483,000 after buying an additional 4,375 shares in the last quarter. Jag Capital Management LLC grew its holdings in JPMorgan Chase & Co. by 10.5% during the fourth quarter. Jag Capital Management LLC now owns 1,474 shares of the financial services provider's stock worth $353,000 after buying an additional 140 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in JPMorgan Chase & Co. by 7.7% during the third quarter. JPMorgan Chase & Co. now owns 4,450,775 shares of the financial services provider's stock worth $938,491,000 after buying an additional 319,730 shares in the last quarter. Institutional investors own 71.55% of the company's stock.

Insider Activity

In other JPMorgan Chase & Co. news, CEO Troy L. Rohrbaugh sold 37,500 shares of the firm's stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $269.84, for a total value of $10,119,000.00. Following the completion of the transaction, the chief executive officer now owns 158,381 shares in the company, valued at $42,737,529.04. This trade represents a 19.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Jennifer Piepszak sold 4,273 shares of the business's stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $269.85, for a total transaction of $1,153,069.05. Following the transaction, the chief operating officer now directly owns 54,469 shares of the company's stock, valued at approximately $14,698,459.65. This represents a 7.27% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 138,617 shares of company stock valued at $35,600,742 over the last quarter. Company insiders own 0.47% of the company's stock.

Analyst Upgrades and Downgrades

JPM has been the topic of several recent analyst reports. Cowen started coverage on JPMorgan Chase & Co. in a research note on Wednesday, May 14th. They set a "buy" rating on the stock. UBS Group raised their price target on shares of JPMorgan Chase & Co. from $277.00 to $305.00 and gave the company a "buy" rating in a research report on Thursday, April 17th. TD Securities upped their price objective on shares of JPMorgan Chase & Co. from $305.00 to $315.00 and gave the stock a "buy" rating in a research report on Tuesday. KGI Securities began coverage on shares of JPMorgan Chase & Co. in a research note on Sunday, April 13th. They issued a "hold" rating for the company. Finally, TD Cowen began coverage on shares of JPMorgan Chase & Co. in a research report on Thursday, May 15th. They set a "buy" rating and a $305.00 target price on the stock. Eleven equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $266.20.

Check Out Our Latest Report on JPMorgan Chase & Co.

JPMorgan Chase & Co. Price Performance

Shares of NYSE JPM opened at $265.55 on Wednesday. The company has a current ratio of 0.88, a quick ratio of 0.89 and a debt-to-equity ratio of 1.24. The stock has a fifty day simple moving average of $242.28 and a two-hundred day simple moving average of $247.67. JPMorgan Chase & Co. has a 1-year low of $190.88 and a 1-year high of $280.25. The firm has a market cap of $737.99 billion, a price-to-earnings ratio of 13.45, a price-to-earnings-growth ratio of 2.83 and a beta of 1.07.

JPMorgan Chase & Co. (NYSE:JPM - Get Free Report) last posted its quarterly earnings results on Friday, April 11th. The financial services provider reported $5.07 earnings per share for the quarter, topping the consensus estimate of $4.63 by $0.44. JPMorgan Chase & Co. had a return on equity of 16.99% and a net margin of 20.96%. The company had revenue of $45.30 billion during the quarter, compared to the consensus estimate of $43.62 billion. During the same quarter in the prior year, the company earned $4.44 EPS. The firm's quarterly revenue was up 8.0% compared to the same quarter last year. Analysts anticipate that JPMorgan Chase & Co. will post 18.1 earnings per share for the current year.

JPMorgan Chase & Co. Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Thursday, July 3rd will be given a dividend of $1.40 per share. The ex-dividend date is Thursday, July 3rd. This represents a $5.60 dividend on an annualized basis and a yield of 2.11%. JPMorgan Chase & Co.'s dividend payout ratio is presently 27.49%.

JPMorgan Chase & Co. Company Profile

(Free Report)

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate.

Recommended Stories

Want to see what other hedge funds are holding JPM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan Chase & Co. (NYSE:JPM - Free Report).

Institutional Ownership by Quarter for JPMorgan Chase & Co. (NYSE:JPM)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in JPMorgan Chase & Co. Right Now?

Before you consider JPMorgan Chase & Co., you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JPMorgan Chase & Co. wasn't on the list.

While JPMorgan Chase & Co. currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines